USPTO serial 99230956
BIORCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 17, 2026
- Examiner
- SNYDER, NELSON B
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIORCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Santarém, PT
Santarém, PT
Santarém, PT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Justin Brown
Justin Brown BROWN BROTHERS LAW, LLP1827 Harley DriveAnn Arbor, MI 48103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software using artificial intelligence models for drug discovery, efficacy analysis of drugs and diagnostic agents, efficacy analysis of medical diagnostics, efficacy analysis of biological products and functional materials used in bio-medicine, and for use in providing advice on testing, research and development on pharmaceuticals, regenerative medicine products, cosmetics, foods, agricultural chemicals and functional materials used in bio-medicine; downloadable computer software with artificial intelligence used for drug discovery screening | ACTIVE | — |
| 042 | Providing online non-downloadable computer software using artificial intelligence for drug discovery screening; providing online non-downloadable computer software using artificial intelligence for analysis, testing, screening, design and research of chemicals, pharmaceuticals and functional materials used in bio-medicine; screening for scientific research purposes and design of chemical compounds acting on drug targets; biochemical analysis and design of compounds for use in pharmaceuticals; drug screening for scientific purposes of chemical compounds used in pharmaceuticals; scientific analysis, scientific testing, design, scientific research and drug screening for scientific purposes of chemicals, pharmaceuticals, and functional materials used in bio-medicine; scientific research and development by contracted parties in the field of drug discovery, drugs, diagnostic agents, medical diagnostics, biological products and functional materials used in bio-medicine; advice on scientific testing, research and development of pharmaceuticals, regenerative medicine products, cosmetics, foods, agricultural chemicals and functional materials used in bio-medicine; Advice and consulting about scientific testing, scientific research, and scientific feasibility studies of pharmaceuticals, regenerative medicine, cosmetics, foods, agricultural chemicals, and functional materials used in bio-medicine; electronic data storage in the nature of leasing of storage space on Internet servers; cloud computing featuring software for use in clinical trial protocol design and feasibility analysis, and for optimizing drug development processes using artificial intelligence; provision of online non-downloadable computer programs for use in advanced data analysis, predictive modeling, and regulatory planning for clinical trials and drug development; design, creation, and maintenance of computer programs; and leasing of computers; Research and development of software using artificial intelligence; testing, inspection, or research of pharmaceuticals, cosmetics, or foods; design, creating and maintenance of computer programs for design, development and research of compounds which are a source of pharmaceuticals; providing temporary use of online non-downloadable computer programs for design, development and research of compounds which are a source of pharmaceuticals; design, creating and maintenance of computer programs for design, development, research and testing of chemicals, pharmaceuticals and chemical compounds; providing temporary use of online non-downloadable computer programs for design, development, research and testing of chemicals, pharmaceuticals and chemical compounds; design, creating and maintenance of computer programs for screening for development of new drugs; providing temporary use of online non-downloadable computer programs for screening for development of new drugs; computer programming; providing temporary use of online non-downloadable computer programs for use in clinical trial protocol design and feasibility analysis, and for optimizing drug development processes using artificial intelligence; research in the field of artificial intelligence | ACTIVE | — |
| 044 | Providing information relating to the diagnostic, disease preventing and healing properties of medicines; providing medical information relating to pharmaceuticals and compounds which are a source of pharmaceuticals; providing of medical information, advice and consultancy; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIORCE, S.A
- Other trademarks owned by BIORCE, S.A
- Other trademarks owned by BIORCE, S.A
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIORCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 29, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 1, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |